The Future of Psychiatric Medicine Is Upon Us…What If There Was A Simple Test That Discovered What Medicine Works Most Effectively With Your Body?
Dr Lombard will discuss how Genomind’s testing helps clinicians find appropriate and effective treatment more quickly and efficiently. Psychiatrists prescribe medication on a trial and error basis, which can be a very long and frustrating road for children and adults who are suffering. Patients who have psychiatric disorders that are difficult to treat such as depression, bipolar disorder, schizophrenia, anxiety disorders, OCD, and ADHD can benefit tremendously from this kind of physiological and genetic testing.
Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. At our core is a belief in the combined power of a caring clinician and scientific research. We work hard every day to bring science to psychiatry and to create new innovations that will help clinicians improve their patients’ lives.
Dr Jay Lombard – co-founder and Chief Scientific Officer and Medical Director at Genomind, a biotechnology company devoted to the discovery of the underlying causes of neuropsychiatric disorders including Alzheimer’s disease, schizophrenia, autism and mood disorders is our guest on Ask Stefanie to discuss the future of prescribing psychotropic medications. Dr. Lombard is a board certified neurologist and is currently a professor of Neurology at Touro College of Osteopathic Medicine. He has published several books on the role of nutrition and the brain and has lectured extensively on this topic as well. He has had numerous television and radio appearances including on Larry King, Dr. Oz, CBS News, Fox News, The Early Morning Show and others.
LISTEN TO THE INTERVIEW Sunday January 19th 9pmE